Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
ARTES and Burnet Institute publish data on production and immunogenicity of malaria transmission-blocking vaccine candidates
/in Allgemein /by Melanie PiontekARTES Biotechnology and Burnet Institute recently published data on the efficient production of malaria vaccine candidates using virus-like particles (VLP) presenting malaria transmission-stage antigens, which were capable of inducing transmission-blocking antibodies.
ARTES attends BioEurope Spring 2019
/in Allgemein /by Melanie PiontekMeet us at the Bio-Europe Spring 2018 taking place in Vienna, Austria March 25 ‑27. Volker Jenzelewski, Director Technology at ARTES, will be present in the One-on-One Partnering presenting ARTES’ innovative range of cell line and process development solutions for bio-pharmaceutical and vaccine products.
SplitCore – the latest milestone in ARTES´ vaccine development offer
/in Allgemein /by Melanie PiontekARTES Biotechnology announces the acquisition of the unique SplitCore technology developed by scientists at the University of Freiburg, Germany.